vs
PagerDuty, Inc.（PD）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是PagerDuty, Inc.的1.7倍（$207.3M vs $124.5M），PagerDuty, Inc.净利率更高（129.7% vs -62.0%，领先191.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 4.7%），PagerDuty, Inc.自由现金流更多（$24.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 5.9%）
PagerDuty是一家美国云计算企业，主打面向IT运维部门的SaaS事件管理平台，可帮助企业实时响应运维异常、快速定位并处理故障，保障业务系统稳定运行，目前已成为全球IT运维领域广受认可的数字化解决方案服务商。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PD vs RARE — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.5M | $207.3M |
| 净利润 | $161.6M | $-128.6M |
| 毛利率 | 85.3% | — |
| 营业利润率 | 6.5% | -54.7% |
| 净利率 | 129.7% | -62.0% |
| 营收同比 | 4.7% | 25.9% |
| 净利润同比 | 2827.7% | 3.5% |
| 每股收益（稀释后） | $1.69 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $124.5M | $207.3M | ||
| Q3 25 | $123.4M | $159.9M | ||
| Q2 25 | $119.8M | $166.5M | ||
| Q1 25 | $121.4M | $139.3M | ||
| Q4 24 | $118.9M | $164.6M | ||
| Q3 24 | $115.9M | $139.5M | ||
| Q2 24 | $111.2M | $147.0M | ||
| Q1 24 | $111.1M | $108.8M |
| Q4 25 | $161.6M | $-128.6M | ||
| Q3 25 | $9.6M | $-180.4M | ||
| Q2 25 | $-7.2M | $-115.0M | ||
| Q1 25 | $-8.8M | $-151.1M | ||
| Q4 24 | $-5.9M | $-133.2M | ||
| Q3 24 | $-10.9M | $-133.5M | ||
| Q2 24 | $-17.1M | $-131.6M | ||
| Q1 24 | $-28.2M | $-170.7M |
| Q4 25 | 85.3% | — | ||
| Q3 25 | 84.6% | — | ||
| Q2 25 | 84.0% | — | ||
| Q1 25 | 83.6% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 82.7% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.7% | — |
| Q4 25 | 6.5% | -54.7% | ||
| Q3 25 | 2.9% | -106.9% | ||
| Q2 25 | -8.6% | -64.8% | ||
| Q1 25 | -9.6% | -102.6% | ||
| Q4 24 | -8.7% | -74.3% | ||
| Q3 24 | -13.8% | -94.6% | ||
| Q2 24 | -19.5% | -79.1% | ||
| Q1 24 | -30.1% | -151.9% |
| Q4 25 | 129.7% | -62.0% | ||
| Q3 25 | 7.8% | -112.8% | ||
| Q2 25 | -6.0% | -69.0% | ||
| Q1 25 | -7.2% | -108.5% | ||
| Q4 24 | -5.0% | -80.9% | ||
| Q3 24 | -9.4% | -95.7% | ||
| Q2 24 | -15.4% | -89.5% | ||
| Q1 24 | -25.3% | -156.8% |
| Q4 25 | $1.69 | $-1.28 | ||
| Q3 25 | $0.10 | $-1.81 | ||
| Q2 25 | $-0.07 | $-1.17 | ||
| Q1 25 | $-0.12 | $-1.57 | ||
| Q4 24 | $-0.07 | $-1.34 | ||
| Q3 24 | $-0.14 | $-1.40 | ||
| Q2 24 | $-0.26 | $-1.52 | ||
| Q1 24 | $-0.34 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $547.8M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $320.5M | $-80.0M |
| 总资产 | $1.0B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $547.8M | $421.0M | ||
| Q3 25 | $567.9M | $202.5M | ||
| Q2 25 | $597.1M | $176.3M | ||
| Q1 25 | $570.8M | $127.1M | ||
| Q4 24 | $542.2M | $174.0M | ||
| Q3 24 | $599.3M | $150.6M | ||
| Q2 24 | $592.8M | $480.7M | ||
| Q1 24 | $571.2M | $112.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $484.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $489.5M | — |
| Q4 25 | $320.5M | $-80.0M | ||
| Q3 25 | $180.7M | $9.2M | ||
| Q2 25 | $145.7M | $151.3M | ||
| Q1 25 | $129.8M | $144.2M | ||
| Q4 24 | $111.6M | $255.0M | ||
| Q3 24 | $164.7M | $346.8M | ||
| Q2 24 | $174.0M | $432.4M | ||
| Q1 24 | $171.6M | $140.3M |
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $891.5M | $1.2B | ||
| Q2 25 | $926.8M | $1.3B | ||
| Q1 25 | $927.3M | $1.3B | ||
| Q4 24 | $866.8M | $1.5B | ||
| Q3 24 | $916.0M | $1.5B | ||
| Q2 24 | $924.0M | $1.6B | ||
| Q1 24 | $925.3M | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.73× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.85× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $24.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $24.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 19.3% | -48.6% |
| 资本支出强度资本支出/营收 | 0.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.15× | — |
| 过去12个月自由现金流最近4个季度 | $117.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $24.8M | $-99.8M | ||
| Q3 25 | $34.0M | $-91.4M | ||
| Q2 25 | $30.7M | $-108.3M | ||
| Q1 25 | $31.4M | $-166.5M | ||
| Q4 24 | $22.1M | $-79.3M | ||
| Q3 24 | $35.8M | $-67.0M | ||
| Q2 24 | $28.6M | $-77.0M | ||
| Q1 24 | $22.2M | $-190.7M |
| Q4 25 | $24.1M | $-100.8M | ||
| Q3 25 | $33.1M | $-92.7M | ||
| Q2 25 | $30.2M | $-110.7M | ||
| Q1 25 | $30.3M | $-167.8M | ||
| Q4 24 | $21.5M | $-79.5M | ||
| Q3 24 | $35.1M | $-68.6M | ||
| Q2 24 | $28.2M | $-79.0M | ||
| Q1 24 | $21.2M | $-193.9M |
| Q4 25 | 19.3% | -48.6% | ||
| Q3 25 | 26.8% | -58.0% | ||
| Q2 25 | 25.2% | -66.5% | ||
| Q1 25 | 24.9% | -120.5% | ||
| Q4 24 | 18.1% | -48.3% | ||
| Q3 24 | 30.3% | -49.2% | ||
| Q2 24 | 25.4% | -53.7% | ||
| Q1 24 | 19.1% | -178.2% |
| Q4 25 | 0.6% | 0.5% | ||
| Q3 25 | 0.7% | 0.8% | ||
| Q2 25 | 0.4% | 1.5% | ||
| Q1 25 | 0.9% | 1.0% | ||
| Q4 24 | 0.5% | 0.1% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.4% | 1.4% | ||
| Q1 24 | 0.9% | 3.0% |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 3.55× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
